-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, AY7LCRcEYQ+d5FvW6NLHdA0XJ8u+WJLVqaZ08XtOsptnQfSb29bnt8Ow4jqN/Z1C COB5Kc9D8Y4hFloY+tFtkg== 0001014865-96-000009.txt : 19960910 0001014865-96-000009.hdr.sgml : 19960910 ACCESSION NUMBER: 0001014865-96-000009 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 19960906 SROS: NASD SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: AMARILLO BIOSCIENCES INC CENTRAL INDEX KEY: 0001014763 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 751974352 STATE OF INCORPORATION: TX FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-46755 FILM NUMBER: 96626306 BUSINESS ADDRESS: STREET 1: 800 W 9TH AVE CITY: AMARILLO STATE: TX ZIP: 79101-3206 BUSINESS PHONE: 8063761741 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: HAYASHIBARA BIOCHEMICAL LABORATORIES INC CENTRAL INDEX KEY: 0001021776 STANDARD INDUSTRIAL CLASSIFICATION: [] FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: 2-3 SHIMOISHII 1-CHOME STREET 2: OKAYAMA 700 JAPAN STATE: M0 BUSINESS PHONE: 81862244311 MAIL ADDRESS: STREET 1: 2-3 SHIMOISHII 1-CHOME STREET 2: OKAYAMA 700 JAPAN STATE: M0 SC 13G 1 HAYASHIBARA BIOCHEMICAL LABORATORIES INC.'S 13G - ------------------------------ OMB APPROVAL - ------------------------------ OMB Number: 3235-0145 Expires: October 31, 1994 Estimated average burden hours per response.....14.90 - ------------------------------ SCHEDULE 13G INFORMATION STATEMENT PURSUANT TO RULES 13d-1 and 13d-2 UNDER THE SECURITIES EXCHANGE ACT OF 1934 (AMENDMENT NO. )* AMARILLO BIOSCIENCES, INC. -------------------------- (Name of Issuer) Common Stock, par value $.01 per share -------------------------------------- (Title of Class of Securities) 02301P106 --------- (CUSIP Number) Check the following box if a fee is being paid with this statement [X]. (A fee is not required only if the filing person: (1) has a previous statement on file reporting beneficial ownership of more than five percent of the class of securities described in Item 1; and (2) has filed no amendment subsequent thereto reporting beneficial ownership of five percent or less of such class.) (See Rule 13d-7.) * The remainder of this cover page should be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). page 1 of 5 pages SCHEDULE 13G CUSIP No. 02301P106 Page 2 of 5 Pages --------- 1 NAME OF REPORTING PERSONS S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS Hayashibara Biochemical Laboratories, Inc. 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a)[ ] (b)[ ] 3 SEC USE ONLY 4 CITIZENSHIP OR PLACE OR ORGANIZATION Japan 5 NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH SOLE VOTING POWER 1,232,856 6 NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH SHARED VOTING POWER None 7 NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH SOLE DISPOSITIVE POWER 1,232,856 8 NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH SHARED DISPOSITIVE POWER None 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 1,232,856 10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* [ ] 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 24.1% 12 TYPE OF REPORTING PERSON* CO *SEE INSTRUCTION BEFORE FILLING OUT! page 2 of 5 pages ITEM 1(A). NAME OF ISSUER: Amarillo Biosciences, Inc. ITEM 1(B). ADDRESS OF ISSUER'S PRINCIPAL EXECUTIVE OFFICES: 800 West 9th Avenue Amarillo, Texas 79101 ITEM 2(A). NAME OF PERSON FILING: This statement is being filed by Hayashibara Biochemical Laboratories, Inc., a Japanese corporation ("HBL"). HBL is making the filing because it owns of record the shares of Common Stock, par value $.01 per share, of Amarillo Biosciences, Inc. reported as beneficially owned by it. ITEM 2(B). ADDRESS OF PRINCIPAL BUSINESS OFFICE, OR, IF NONE, RESIDENCE: The principal business office of HBL is 2-3, Shimoishii 1-chome, Okayama 700, Japan. ITEM 2(C). CITIZENSHIP: HBL is a Japanese corporation. ITEM 2(D). TITLE OF CLASS OF SECURITIES: Common Stock, par value $.01 per share, of Amarillo Biosciences, Inc. ("Common Stock") ITEM 2(E). CUSIP NUMBER: 02301P106 ITEM 3. IF THIS STATEMENT IS FILED PURSUANT TO RULE 13D-1(B), OR 13D-2(B), CHECK WHETHER THE PERSON IS: Not applicable ITEM 4. OWNERSHIP: (a) Amount Beneficially Owned: 1,232,856 shares (b) Percent of Class: 24.1% page 3 of 5 pages (c) Number of shares as to which such person has: (i) sole power to vote or direct the vote: 1,232,856 (ii) shared power to vote or direct the vote: None (iii) sole power to dispose or direct the disposition of: 1,232,856 (iv) shared power to dispose or direct the disposition of: None ITEM 5. OWNERSHIP OF FIVE PERCENT OR LESS OR A CLASS. If this statement is being filed to report the fact that as of the date hereof, the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following. [ ] ITEM 6. OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON. Not applicable ITEM 7. IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY. Not applicable ITEM 8. IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP. Not applicable ITEM 9. NOTICE OF DISSOLUTION OF GROUP. Not applicable. ITEM 10. CERTIFICATION. Not applicable. page 4 of 5 pages SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Dated: September 5, 1996 HAYASHIBARA BIOCHEMICAL LABORATORIES, INC. By /s/ Katsuaki Hayashibara ---------------------------- Name: Katsuaki Hayashibara Title: Director of Research and Development page 5 of 5 pages -----END PRIVACY-ENHANCED MESSAGE-----